ARCHIVES

In Brief: Sharp Won’t Take MIT Presidency; Brow returns To NCI; Goldman Succeeds Lawrence At MCV

This article is from The Cancer Letter archive.

Vol. 16 No. 10 | March 9, 1990

Download PDF Visit The Full Archive

Related Articles

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

In Brief: Chairmen Named For New Organ Systems Working Groups; Powers Out As OSP Committee Chairman

September 28, 1984

Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve

February 21, 1975

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987

Funding opportunities listed.

February 6, 2004